GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dabomb Protein Biotech 6578.TWO · TWD

Consumer Staples · Taipei Exchange · 🇹🇼 Taiwan

Compare

16.90

0.00%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Dabomb Protein Biotech

Its shares trade on Taipei Exchange under the ticker 6578.TWO. It has been listed since 20 July 2016. In the fiscal year to 31 December 2025, it reported revenue of TWD 309.3m and a net loss of TWD 69.3m. At that date it held total assets of TWD 1.10bn and shareholders' equity of TWD 989.3m.

DaBomb Protein Corp. manufactures and supply hydrolyzed soya peptide. The company is headquartered in Tainan, Tainan. The company went IPO on 2016-07-20. Its main products include hydrolyzed soy peptide protein and functional peptide. Its products are mainly used in aquatic, livestock and other protein materials and functional health products. Its customers include feed factories, animal farms and aquaculture farms. The firm markets its products to domestic and foreign markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
20 Jul 2016

Leadership

Pay as last reported

  • Ms. Yu-Fen LiuChairman of the Board, since 2014
  • Wei-Chen ChenGeneral Manager
  • Mr. Zonghua YouDeputy General Manager-Production Division
  • Ms. Yahui YaoHead of Accounting
  • Chih-Chen LinDirector
  • Ms. Chiou-Ru ShihDirector
  • Xianji YangDirector
  • Ms. Xueling CaiIndependent Director
  • Mr. Huawei HuangIndependent Director
  • Yuting HuangIndependent Director
  • Guoping WuIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • DaBomb Protein Biotech Corp manufactures hydrolyzed soya peptide for aquatic and livestock markets.
  • The company's functional peptide products are used in health and protein materials globally.
  • DaBomb Protein Biotech Corp has a strong presence in domestic and international markets since 2016.

Weaknesses

  • DaBomb Protein Biotech Corp relies on hydrolyzed soy peptide as its main product line.
  • The company's business is concentrated in feed factories and animal farms for distribution.
  • DaBomb Protein Biotech Corp has limited product diversification beyond protein materials.

Opportunities

  • Expanding into functional health products could increase market share in the health sector.
  • Growing demand for protein materials in aquaculture presents new opportunities.
  • International market expansion could leverage existing domestic success in 2016.

Threats

  • Competition from other protein material suppliers in the aquatic market.
  • Economic downturns affecting livestock and aquaculture industries globally.
  • Regulatory changes in the Consumer Staples sector could impact operations.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.